SAFETY MONITORING GUIDELINES FOR TREATMENTS FOR MAJOR DEPRESSIVE DISORDER

被引：0

作者：

Dodd, S. ^{[1
,2
]}

Malhi, G. S.

Tiller, J. ^{[4
]}

Schweitzer, I. ^{[4
]}

Hickie, I. ^{[3
]}

Khoo, J. P. ^{[5
]}

Basset, D. L. ^{[6
]}

Lyndon, B.

Mitchell, P. B. ^{[7
]}

Parker, G. ^{[7
]}

Fitzgerald, P. B. ^{[8
]}

Udina, M. ^{[9
]}

Singh, A. ^{[2
]}

Moylan, S. ^{[1
]}

Giorlando, F. ^{[2
]}

Doughty, C. ^{[10
]}

Davey, C. G. ^{[11
]}

Theodoros, M. ^{[12
]}

Berk, M. ^{[1
,2
,11
]}

机构：

[1] Deakin Univ, Geelong, Vic 3217, Australia

[2] Univ Melbourne, Geelong, Vic, Australia

[3] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia

[4] Univ Melbourne, Melbourne, Vic, Australia

[5] Toowong Specialist Clin, Brisbane, Qld, Australia

[6] Univ Western Australia, Perth, WA 6009, Australia

[7] Univ New S Wales, Sydney, NSW, Australia

[8] Monash Univ, Melbourne, Vic 3004, Australia

[9] Univ Barcelona, Barcelona, Spain

[10] Univ Otago, Christchurch, New Zealand

[11] Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia

[12] New Farm Clin, Brisbane, Qld, Australia

来源：

EUROPEAN PSYCHIATRY | 2012年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

O-10

引用

页数：1

共 50 条

[21] Unconventional treatments with unique mechanistic targets for major depressive disorder: ketamine [J].

Vazquez, G. .

EUROPEAN PSYCHIATRY, 2020, 63 :S605-S605

[22] Unconventional treatments with unique mechanistic targets for major depressive disorder: cannabinoids [J].

Bahji, A. .

EUROPEAN PSYCHIATRY, 2020, 63 :S605-S605

[23] Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelines [J].

Simons, Peter ;

Cosgrove, Lisa ;

Shaughnessy, Allen F. ;

Bursztajn, Harold .

INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2017, 55 :64-71

[24] Major depressive disorder in the general hospital:: adaptation of clinical practice guidelines [J].

Voellinger, R ;

Berney, A ;

Baumann, P ;

Annoni, JM ;

Bryois, C ;

Buclin, T ;

Büla, C ;

Camus, V ;

Christin, L ;

Cornuz, J ;

de Goumoëns, P ;

Lamy, O ;

Strnad, J ;

Burnand, B ;

Stiefel, F .

GENERAL HOSPITAL PSYCHIATRY, 2003, 25 (03) :185-193

[25] Duloxetine in the treatment of major depressive disorder: Comparisons of safety and efficacy [J].

Bailey, RK ;

Mallinckrodt, CH ;

Wohlreich, MM ;

Watkin, JG ;

Plewes, JM .

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (03) :437-447

[26] Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder [J].

Kryst, Joanna ;

Kawalec, Pawel ;

Pilc, Andrzej .

EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) :9-20

[27] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments [J].

Milev, Roumen V. ;

Giacobbe, Peter ;

Kennedy, Sidney H. ;

Blumberger, Daniel M. ;

Daskalakis, Zafiris J. ;

Downar, Jonathan ;

Modirrousta, Mandana ;

Patry, Simon ;

Vila-Rodriguez, Fidel ;

Lam, Raymond W. ;

MacQueen, Glenda M. ;

Parikh, Sagar V. ;

Ravindran, Arun V. .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09) :561-575

[28] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments [J].

Kennedy, Sidney H. ;

Lam, Raymond W. ;

McIntyre, Roger S. ;

Tourjman, S. Valerie ;

Bhat, Venkat ;

Blier, Pierre ;

Hasnain, Mehrul ;

Jollant, Fabrice ;

Levitt, Anthony J. ;

MacQueen, Glenda M. ;

McInerney, Shane J. ;

McIntosh, Diane ;

Milev, Roumen V. ;

Mueller, Daniel J. ;

Parikh, Sagar V. ;

Pearson, Norma L. ;

Ravindran, Arun V. ;

Uher, Rudolf .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09) :540-560

[29] GEPIRONE ER - AN EFFICACY AND SAFETY TRIAL IN MAJOR DEPRESSIVE DISORDER [J].

CUTLER, NR ;

JENKINS, S ;

SRAMEK, JJ ;

DOSS, MG ;

PRESTON, TV .

BIOLOGICAL PSYCHIATRY, 1993, 33 (6A) :A82-A82

[30] Efficacy and safety of nefazadone in the treatment of adolescents with major depressive disorder [J].

Emslie, GJ ;

Findling, RL ;

Rynn, MA ;

Marcus, RN ;

Fernandes, LA ;

D'Amico, MF ;

Hardy, SA .

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2002, 12 (04) :299-299

← 1 2 3 4 5 →